Citation Impact
Citing Papers
LEF1 and B9L Shield β-Catenin from Inactivation by Axin, Desensitizing Colorectal Cancer Cells to Tankyrase Inhibitors
2014
Characterizing and explaining the impact of disease-associated mutations in proteins without known structures or structural homologs
2022 StandoutNobel
MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect
2019
A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53 -mutant Ovarian Cancer
2020
Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
2016
A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth
2013
Distinct Colorectal Cancer–Associated APC Mutations Dictate Response to Tankyrase Inhibition
2019
T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
2018
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway
2014
The evolutionary history of human spindle genes includes back-and-forth gene flow with Neandertals
2022 StandoutNobel
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Transcriptional Regulation by Nrf2
2017 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
UALCAN: An update to the integrated cancer data analysis platform
2022 Standout
Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells
2013
The evidence framework for precision cancer medicine
2017
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
2019
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
2020 StandoutNobel
In vivo wide-area cellular imaging by side-view endomicroscopy
2010
Microsatellite Instability in Colorectal Cancer
2010 Standout
Hepatocellular carcinoma
2016 Standout
Biology of colorectal cancer
2015
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
ROS in cancer therapy: the bright side of the moon
2020 Standout
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
2011
Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer
2015
Wnt signaling in cancer
2016 Standout
The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway
2019 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Optimized base editors enable efficient editing in cells, organoids and mice
2018
Effective gene expression prediction from sequence by integrating long-range interactions
2021 StandoutNobel
Cancer stem cells revisited
2017 Standout
Clinical Overview of MDM2/X-Targeted Therapies
2016
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Non-coding driver mutations in human cancer
2021
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
2016
Targeting apoptosis in cancer therapy
2020 Standout
Why are there hotspot mutations in the TP53 gene in human cancers?
2017
An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
2018
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
2015
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Artificial intelligence in drug development: present status and future prospects
2018 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Monitoring Keap1–Nrf2 interactions in single live cells
2014
Targeting mutant p53 for efficient cancer therapy
2017
Drugging Wnt signalling in cancer
2012
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function
2015 Nature
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
2017
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
2019 Nature
Molecular profiling for precision cancer therapies
2020
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Tumor microenvironment and cancer therapy resistance
2015
CADD: predicting the deleteriousness of variants throughout the human genome
2018 Standout
Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
2017
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
2013
Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
2017
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Redox Signaling by Reactive Electrophiles and Oxidants
2018
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Works of Dmitriy Sonkin being referenced
Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling
2014
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
2013
Somatic cancer variant curation and harmonization through consensus minimum variant level data
2016
Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity
2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
2016
Genetic Mechanisms in Apc-Mediated Mammary Tumorigenesis
2009
Tumor Suppressors Status in Cancer Cell Line Encyclopedia
2013
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
2015
ClinGen Cancer Somatic Working Group – standardizing and democratizing access to cancer molecular diagnostic data to drive translational research
2017
TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
2016
Maintenance of adenomatous polyposis coli ( APC )-mutant colorectal cancer is dependent on Wnt/β-catenin signaling
2011